Psoriatic arthritis trials in Greece
4 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
- Where
- Thessaloniki
- Age
- 5 years to 18 years
- People
- 48 worldwide
- Run by
- Amgen
See details and how to joinNCT05767047 - Phase 3Taking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Athens, Chaïdári, Thessaloniki
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - No phaseNot yet taking people in GreecePrevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study
- Where
- Thessaloniki
- Age
- 18 years and over
- People
- 72 worldwide
- Run by
- Sociedade Portuguesa de Reumatologia
See details and how to joinNCT07772544 - Phase 3Not yet taking people in GreeceA study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
- Where
- Athens, Chaïdári, Heraklion
- Age
- 18 years and over
- People
- 948 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00